Kieran O’Kane is Chief Commercial Officer, Biodesix, since March 2020 and has been with the Company in marketing management and corporate development roles since February 2018. Kieran is an experienced commercial leader with a career focus in oncology. His depth of experience, stemming from an academic background in Pharmacology, over 23 years in the industry including over 10 product launches globally across pharma, medical device and clinical diagnostics and a strong personal motivation to positively impact health outcomes is the basis of his overall success in driving commercial growth at Biodesix.
Prior to joining Biodesix, Kieran led the Global Diagnostics Marketing team at Nanostring Technologies, a biotechnology company focused on developing cancer diagnostic tools. Kieran held various commercial leadership positions in sales and marketing functions, in addition to managing pricing, reimbursement, health technology appraisal and national payor strategy at companies including Biotheranostics, Cell Therapeutics, Eisai, Cephalon, Bristol-Myers Squibb, and Roche.